Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Diamedica Therapeutics Inc (DMAC)

Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Diamedica Therapeutics Inc 301 CARLSON PARKWAY SUITE 210 MINNETONKA MN 55305 USA

www.diamedica.com Employees: 19 P: 763-496-5454

Description:

DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada. DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota.

Key Statistics

Overview:

Market Capitalization, $K 181,679
Enterprise Value, $K 177,139
Shares Outstanding, K 42,748
Annual Sales, $ 0 K
Annual Net Income, $ -19,380 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,120 K
EBIT, $ -22,390 K
EBITDA, $ -23,580 K
60-Month Beta 1.46
% of Insider Shareholders 7.20%
% of Institutional Shareholders 10.12%
Float, K 39,670
% Float 92.80%
Short Volume Ratio 0.42

Growth:

1-Year Return 74.41%
3-Year Return -8.60%
5-Year Return 41.20%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 18.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 08/07/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -0.53
EPS Growth vs. Prev Qtr 7.14%
EPS Growth vs. Prev Year 18.75%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

DMAC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -38.56%
Return-on-Assets % -36.46%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.50
Book Value/Share 1.25
Interest Coverage -1.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar